Ex-Texas governor, W. Bryan Hubbard, and Joe Rogan explore Ibogaine's potential as breakthrough in addiction treatment

In episode #2251 of The Joe Rogan Experience podcast, Rick Perry and W. Bryan Hubbard joined Joe Rogan to discuss the benefits of ibogaine as a treatment for addiction.

Perry, the 47th Governor of Texas, is working hard to educate people about the potential of ibogaine in controlling addiction. During the podcast, he highlighted three major benefits of this drug.

Perry emphasized the third benefit as the most significant, explaining that it takes users on a spiritual journey, allowing them to feel a divine presence. Perry stated:

“Number one It resolves physiological substance dependence on an accelerated time frame in a manner that frees an individual from the physical consequences of their dependencies. Number 2 It has a profound psychological effect for the individual whereby on the back end of treatment, having been physiologically restored.”

Perry added:

“Finally, and most significantly, many people, the overwhelming majority of folks who have an ibogaine experience, come away with an affirmation that they are a spiritual being who is made in the image of an eternal Creator whose essence is pure and unconditional love. That creator has conferred special and unique purpose on their life to be achieved when those three qualities are embraced.”

Check out Rick Perry’s comments below (1:23:51):

Rogan also shares a similar belief and discussed during the episode that ibogaine is not a recreational drug but rather a powerful tool to stop addiction. Ibogaine, a plant-based drug primarily found in Central Africa, was the focus of the discussion. It is currently not licensed for medical purposes.

---

Rick Perry discusses $42 million public-private partnership for Ibogaine research on Joe Rogan's podcast

In the above-mentioned podcast, Perry revealed his plans to develop Ibogaine as a treatment for opioid use disorder in the country. He mentioned on The Joe Rogan Experience podcast that former Attorney General Daniel Cameron encouraged him to lead the commission for developing the drug. Perry said:

“Attorney General [Daniel] Cameron blessed me to lead the commission on the exploration of setting aside $42 million—5% of the state settlement funds—to create a public-private partnership. A drug developer would match the state's investment on the front end by assuming all legal, logistical, and financial risks associated with securing FDA approval to pursue clinical research trials."

Perry added;

“The goal is to develop ibogaine as a breakthrough therapeutic treatment for opioid use disorder, co-occurring substance use disorders, and any other mental health conditions for which it proves effective.“ (1:25:00)